0001104659-20-097716.txt : 20200821
0001104659-20-097716.hdr.sgml : 20200821
20200821190228
ACCESSION NUMBER: 0001104659-20-097716
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200819
FILED AS OF DATE: 20200821
DATE AS OF CHANGE: 20200821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sender Gary
CENTRAL INDEX KEY: 0001659085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 201124422
MAIL ADDRESS:
STREET 1: C/O SYNERGY PHARMACEUTICALS INC.
STREET 2: 420 LEXINGTON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
a4.xml
4
X0306
4
2020-08-19
0
0001641640
Nabriva Therapeutics plc
NBRV
0001659085
Sender Gary
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Chief Financial Officer
Ordinary Shares
2020-08-19
4
M
0
11250
A
210180
D
Ordinary Shares
2020-08-20
4
F
0
3204
0.6476
D
206976
D
Restricted Share Units
2020-08-19
4
M
0
11250
0
D
Ordinary Shares
11250
0
D
The restricted share units convert into ordinary shares on a one-for-one basis upon vesting of the units.
On January 31, 2018, Nabriva Therapeutics plc (the "Issuer") granted the reporting person 22,500 restricted share units ("RSUs"). Fifty percent (50%) of the RSUs vested on August 19, 2019 upon certifcation by the board of directors of the Issuer of the receipt by the Issuer of approval of a new drug application by the U.S. Food and Drug Administration for lefamulin (the "Performance Condition"), and the remaining fifty percent (50%) of the RSUs vested on the one (1)-year anniversary of the Performance Condition.
/s/ Robert Crotty, by power of attorney
2020-08-21